ONCO/REVEAL
Live / Registered — Registered (as of 28 Jul 2020)
What this means for you
Registered since 28 Jul 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87982295
- Registration number
- 6114090
- Mark type
- Stylized text
- Filed
- 22 Sept 2017
- Published for opposition
- 20 Mar 2018
- Registered
- 28 Jul 2020
- Attorney of record
- Marcus Assefa
Goods and services
- Class 001 — Chemicals: Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and scientific diagnostics research; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research
- Class 005 — Pharmaceuticals: Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments, with the aforementioned reagents being used for medical diagnostic purposes; Biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancer
- Class 009 — Scientific and electric apparatus: Computer software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; computer software for analyzing biological samples; computer software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; computer software for use with reagents and reagent kits, all for use in detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; computer software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing
Owner
- Pillar Biosciences, Inc., Natick, MA, US
- Pillar Biosciences, Inc., Natick, MA, US
- Pillar Biosciences, Inc., Natick, MA, US
Prosecution history
- 28 Jul 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Jul 2020 — REGISTERED-PRINCIPAL REGISTER
- 26 Jun 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Jun 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Jun 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Jun 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 May 2020 — ASSIGNED TO LIE
- 21 May 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Nov 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Nov 2019 — NON-FINAL ACTION E-MAILED
- 26 Nov 2019 — SU - NON-FINAL ACTION - WRITTEN
- 14 Nov 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Nov 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Nov 2019 — USE AMENDMENT FILED
- 13 Nov 2019 — DIVISIONAL PROCESSING COMPLETE